Eli Lilly Chief Financial Officer Lucas Montarce says their weight loss pill is on track to launch in the US in the second quarter, pending approval by the Food and Drug Administration. Montarce says they “feel good about the progress.” He speaks to Katie Greifeld.

Texas Senator Ted Cruz (R) Talks ICE, Self-Driving Cars
10:13

Wachtell Lipton Rosen & Katz Partner Andrew Nussbaum Talks Warner Bros. Sale, Netflix
08:48

Brookfield Asset Management CEO Bruce Flatt Talks Succession, AI and Strategy
12:57